Results for tag: "Oblimersen"

Oblimersen is a type of oncology drug used to treat certain types of cancer. It is a type of antisense oligonucleotide, which works by blocking the production of a specific protein that is involved in the growth and spread of cancer cells. Oblimersen is used in combination with other cancer treatments, such as chemotherapy and radiation therapy, to help reduce the size of tumors and slow the progression of the disease. It is also used to reduce the risk of recurrence after cancer treatment. Oblimersen is approved for use in the United States and Europe, and is available in both oral and intravenous forms. It is also being studied for use in other types of cancer, such as breast, lung, and pancreatic cancer. The Oblimersen market is made up of a variety of companies, including pharmaceutical companies, biotechnology companies, and research organizations. Some of the major players in the market include Genzyme Corporation, GlaxoSmithKline, Merck & Co., and Novartis. Other companies involved in the Oblimersen market include AstraZeneca, Bristol-Myers Squibb, and Pfizer. Show Less Read more